News About: Pharm. Industry
Korean drugmakers hit by rebate
The pharmaceutical industry has never really had a good reputation, either here or elsewhere. Behind the life-curing business are heavy lobbying, dirty politics and giant rebates for favorite buyers, all of which is r...
KPMA criticized for lukewarm attitude
The Korea Pharmaceutical Manufacturers Association (KPMA) needs to take a bold action against the current drug-pricing system, critics say.
They argued the KPMA’s tepid position on the current issue is derived from...
Hanmi to get approval of generic Nexium in US
Hanmi Pharm says it has recently filed an ANDA application for its generic Nexium to the U.S. Food and Drug Administration after completion of clinical trials overseas.
The company plans to obtain the market author...
Diabetes drug 'Avandia' to be pulled from shelves
U.K.-based GlaxoSmithKline (GSK)’s blockbuster anti-diabetes pill “Avandia” will face being banned in the Korean market as the Korea Food and Drug Administration (KFDA) announced a plan to review the drug once again a...
Choongwae Holdings to lower debt level
Choongwae Holdings said on October 25 it would aim to lower its debt level significantly this year compared to last year.
Heavy debt has been cited by analysts as the biggest burden to distract Choongwae's plan of ...
Ahngook opens cGMP plant
Ahngook Pharm has recently started operation of a new cGMP (current Good Manufacturing Practice) plant in Hwasung, Kyunggi Province, which will produce 35 billion won worth of pharmaceuticals in solid and liquid forms...
Abbott Korea’s returned goods policy sparks criticism
After Abbott Korea having expressed its intention to withdraw Reductil (sibutramine), a weight loss pill, from the local market, concerns have risen over its insincere policy of the corresponding returned goods.
In...
KFDA warns price dumping in hospital bidding
The Korea Pharmaceutical Manufacturers Association issued a warning against the possible pricing dumping acts in the local hospitals’ bidding arena.
In a circular letter delivered to the Korean Hospital Association...
Huons to export lidocaine injection to US
Huons Co. said on October 20 that it will export its anesthetic products to the U.S. market within a couple of years while making all-out to make inroad into the European market.
In its recent regulatory filing, th...
Nichiko Pharma to acquire 33.4% stake of Korea's Aprogen
Aprogen Inc, a Daejeon-based manufacturer of diagnostic pharmaceuticals and an affiliated company of Schnell Biopharmaceuticals, said on October 21 that Japan based Nichiiko Pharmaceutical plans to acquire 33.4 percen...
